{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:04:08Z","timestamp":1762506248197},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,30]],"date-time":"2014-01-30T00:00:00Z","timestamp":1391040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0086843","type":"journal-article","created":{"date-parts":[[2014,1,30]],"date-time":"2014-01-30T22:14:31Z","timestamp":1391120071000},"page":"e86843","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Pediatric Solid Tumors"],"prefix":"10.1371","volume":"9","author":[{"given":"Michael L.","family":"Megison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren A.","family":"Gillory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry E.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh C.","family":"Nabers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Mroczek-Musulman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia M.","family":"Waters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer M.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Markert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Yancey","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory K.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Beierle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,1,30]]},"reference":[{"key":"ref1","first-page":"136","article-title":"Hepatoblastoma","volume":"11","author":"JT Stocker","year":"1994","journal-title":"Semin Diagn Pathol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-3468(84)80095-0","article-title":"Thirty years of experience with pediatric primary malignant liver tumors","volume":"19","author":"M Giacomantonio","year":"1984","journal-title":"J Pediatr Surg"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Allan BJ, Parikh PP, Diaz S, Perez EA, Neville HL, <etal>et al<\/etal>.. (2013) Predictors of survival and incidence of hepatoblastoma in the paediatric population. HPB (Oxford) doi: 10.1111\/hpb.12112. [Epub ahead of print].","DOI":"10.1111\/hpb.12112"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00043426-200102000-00007","article-title":"Clinical presentation of rhabdoid tumors of the kidney","volume":"23","author":"AM Amar","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jss.2010.03.061","article-title":"Pediatric non-Wilms renal tumors: subtypes, survival, and prognostic indicators","volume":"163","author":"Y Zhuge","year":"2010","journal-title":"J Surg Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/pbc.22922","article-title":"Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: a report of the SIOP renal tumour study group","volume":"56","author":"MM van den Heuvel-Eibrink","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jpedsurg.2008.03.052","article-title":"Fetal and neonatal renal tumors","volume":"43","author":"H Isaacs","year":"2008","journal-title":"J Pediatr Surg"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2243::AID-CNCR24>3.0.CO;2-V","article-title":"Is primitive neuroectodermal tumor of the kidney a distinct entity?","volume":"79","author":"C Rodriguez-Galindo","year":"1997","journal-title":"Cancer"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/1097-0142(19880115)61:2<349::AID-CNCR2820610226>3.0.CO;2-0","article-title":"Malignant peripheral neuroectodermal tumors. A retrospective analysis of 42 patients","volume":"61","author":"H J\u00fcrgens","year":"1988","journal-title":"Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1002\/1097-0142(19891101)64:9<1952::AID-CNCR2820640931>3.0.CO;2-W","article-title":"Peripheral primitive neuroectodermal tumor (peripheral neuroepithelioma) in children. A review of the St. Jude experience and controversies in diagnosis and management","volume":"64","author":"NM Marina","year":"1989","journal-title":"Cancer"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/1097-0142(19910401)67:7<1825::AID-CNCR2820670702>3.0.CO;2-3","article-title":"Extracranial primitive neuroectodermal tumors. The Memorial Sloan-Kettering Cancer Center experience","volume":"67","author":"BH Kushner","year":"1991","journal-title":"Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"10127","DOI":"10.1158\/0008-5472.CAN-06-2744","article-title":"Effective treatment of tumors with strong beta-catenin\/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector","volume":"66","author":"T Kuroda","year":"2006","journal-title":"Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1111\/j.1478-3231.2011.02628.x","article-title":"Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer","volume":"31","author":"R Argnani","year":"2011","journal-title":"Liver Int"},{"key":"ref14","first-page":"1561","article-title":"Antitumor effects of two newly constructed oncolytic herpes simplex viruses against renal cell carcinoma","volume":"30","author":"X Fu","year":"2007","journal-title":"Int J Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1128\/JVI.06998-11","article-title":"Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12","volume":"86","author":"JM Markert","year":"2012","journal-title":"J Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1073\/pnas.040557897","article-title":"Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors","volume":"97","author":"JN Parker","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1128\/JVI.69.6.3615-3623.1995","article-title":"The regulation of synthesis and properties of the protein product of open reading frame P of the herpes simplex virus 1 genome","volume":"69","author":"M Lagunoff","year":"1995","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e77753","DOI":"10.1371\/journal.pone.0077753","article-title":"Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of neuroblastoma","volume":"8","author":"LA Gillory","year":"2013","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1593\/tlo.12505","article-title":"FAK inhibition decreases hepatoblastoma survival both in vitro and in vivo","volume":"6","author":"LA Gillory","year":"2013","journal-title":"Transl Oncol"},{"key":"ref20","first-page":"375","article-title":"The G401 cell line, utilized for studies of chromosomal changes in Wilms\u2019 tumor, is derived from a rhabdoid tumor of the kidney","volume":"142","author":"AJ Garvin","year":"1993","journal-title":"Am J Pathol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/pbc.21099","article-title":"SK-NEP-1 and Rh1 are Ewing family tumor lines","volume":"50","author":"MA Smith","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"ref22","first-page":"164","article-title":"Evaluation of cell-proliferation antibodies reactive in paraffin sections","volume":"2","author":"L Kelleher","year":"1994","journal-title":"Appl Immunohistochem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.4161\/cc.9.5.10936","article-title":"Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma","volume":"9","author":"EA Beierle","year":"2010","journal-title":"Cell Cycle"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/sj.gt.3300550","article-title":"Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins","volume":"5","author":"S Andreansky","year":"1998","journal-title":"Gene Therapy"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10585-012-9560-7","article-title":"FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma","volume":"30","author":"ML Megison","year":"2013","journal-title":"Clin Exp Metastasis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11060-009-9926-0","article-title":"Engineered herpes simplex viruses efficiently infect and kill CD133+ human glioma xenograft cells that express CD111","volume":"95","author":"GK Friedman","year":"2009","journal-title":"J Neurooncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/sj.gt.3300546","article-title":"Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors","volume":"5","author":"SJ Advani","year":"1998","journal-title":"Gene Therapy"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"9479","DOI":"10.1158\/0008-5472.CAN-05-1927","article-title":"Ionizing radiation activates late herpes simplex virus 1 promoters via the p38 pathway in tumors treated with oncolytic viruses","volume":"65","author":"JJ Mezhir","year":"2005","journal-title":"Cancer Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/gt.2011.61","article-title":"Increased oncolytic efficacy for high-grade gliomas by optimal integration of ionizing radiation into the replicative cycle of HSV-1","volume":"18","author":"SJ Advani","year":"2011","journal-title":"Gene Ther"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0014-5793(02)02467-5","article-title":"Targeted cytosolic delivery of hydrogel nanoparticles into HepG2 cells through engineered Sendai viral envelopes","volume":"515","author":"SS Jana","year":"2002","journal-title":"FEBS Lett"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/1471-2407-12-427","article-title":"Engineered measles virus Edmonston strain used as a novel oncolytic viral system against human hepatoblastoma","volume":"12","author":"SC Zhang","year":"2012","journal-title":"BMC Cancer"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/sj.gt.3301620","article-title":"The use of a genetically engineered herpes simplex virus (R7020) with ionizing radiation for experimental hepatoma","volume":"9","author":"SM Chung","year":"2002","journal-title":"Gene Ther"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/mt.2009.73","article-title":"Herpes simplex virus oncolytic therapy for pediatric malignancies","volume":"17","author":"GK Friedman","year":"2009","journal-title":"Mol Ther"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00043426-200208000-00008","article-title":"Differential susceptibility of pediatric sarcoma cells to oncolysis by conditionally replication-competent herpes simplex viruses","volume":"24","author":"NS Bharatan","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/pbc.24117","article-title":"CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV","volume":"60","author":"JG Pressey","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"9304","DOI":"10.1128\/JVI.01826-08","article-title":"Modification and reorganization of the cytoprotective cellular chaperone Hsp27 during herpes simplex virus type 1 infection","volume":"83","author":"SS Mathew","year":"2009","journal-title":"J Virol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.virol.2004.02.005","article-title":"Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus","volume":"322","author":"C Krummenacher","year":"2004","journal-title":"Virology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/pbc.24419","article-title":"COG Renal Tumors Committee. Children\u2019s Oncology Group\u2019s 2013 blueprint for research: renal tumors","volume":"60","author":"JS Dome","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/pbc.22535","article-title":"Initial testing of the replication competent Seneca Valley virus (NTX-010) by the pediatric preclinical testing program","volume":"55","author":"CL Morton","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.athoracsur.2005.01.048","article-title":"Radiation therapy potentiates effective oncolytic viral therapy in the treatment of lung cancer","volume":"80","author":"PS Adusumilli","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1245\/s10434-006-9127-4","article-title":"Radiation-induced cellular DNA damage repair response enhances viral gene therapy efficacy in the treatment of malignant pleural mesothelioma","volume":"14","author":"PS Adusumilli","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1089\/10430340252837224","article-title":"Replication-selective herpes simplex virus type 1 mutant therapy of cervical cancer is enhanced by low-dose radiation","volume":"13","author":"SV Blank","year":"2002","journal-title":"Hum Gene Ther"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1215\/S1152851705000074","article-title":"Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model","volume":"7","author":"EK Hellums","year":"2005","journal-title":"Neuro Oncol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2249.2011.04421.x","article-title":"\u03b1-Fetoprotein impairs activation of natural killer cells by inhibiting the function of dendritic cells","volume":"165","author":"M Yamamoto","year":"2011","journal-title":"Clin Exp Immunol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0086843","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T21:56:48Z","timestamp":1597442208000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0086843"}},"subtitle":[],"editor":[{"given":"Joseph Charles","family":"Glorioso","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,30]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0086843","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,30]]}}}